Cite
HARVARD Citation
Xu, S. et al. (2015). A phase 3, multicenter, randomized, allopurinol‐controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia. International journal of rheumatic diseases. pp. 669-678. [Online].